| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.972 | 41.284 | 106.099 | 80.753 | 46.484 | 43.492 | 43.325 | 88.201 | 99.294 | 22.953 |
| Total Income - EUR | 64.643 | 43.449 | 107.668 | 82.004 | 48.946 | 45.886 | 45.801 | 91.568 | 100.861 | 23.132 |
| Total Expenses - EUR | 47.649 | 33.550 | 44.758 | 48.159 | 28.617 | 30.433 | 28.026 | 37.181 | 36.642 | 14.305 |
| Gross Profit/Loss - EUR | 16.994 | 9.899 | 62.910 | 33.846 | 20.330 | 15.453 | 17.775 | 54.387 | 64.220 | 8.828 |
| Net Profit/Loss - EUR | 13.840 | 8.631 | 59.726 | 31.423 | 18.892 | 14.211 | 16.560 | 53.011 | 55.138 | 7.324 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ro Scientific S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40 | 0 | 0 | 0 | 1.060 | 645 | 244 | 0 | 0 | 0 |
| Current Assets | 294.436 | 14.281 | 84.320 | 105.215 | 120.896 | 123.429 | 135.439 | 78.897 | 130.810 | 13.321 |
| Inventories | 0 | 270 | 2.553 | 260 | 1.262 | 0 | 149 | 20 | 0 | 0 |
| Receivables | 49 | 99 | 45.906 | 26 | 153 | 65 | 218 | 39.362 | 56.199 | 681 |
| Cash | 91.913 | 13.913 | 35.860 | 104.930 | 119.480 | 123.365 | 135.072 | 39.516 | 74.611 | 12.640 |
| Shareholders Funds | 291.819 | 11.159 | 70.696 | 100.822 | 117.761 | 123.212 | 133.848 | 61.256 | 116.208 | 7.373 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.819 | 3.254 | 13.686 | 4.473 | 4.272 | 862 | 1.834 | 17.735 | 14.715 | 6.189 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Ro Scientific S.r.l.